Delivery Order SPE2DB22D2206-SPE2DB25FJL60
Award Date 8/17/25
Potential Completion Date 8/18/25
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,934.37 to AmerisourceBergen Drug Corp for the supply of Neupogen 480 mcg/1.6 mL vials on July 28, 2025. This is a firm fixed-price delivery order with an ultimate completion date of July 29, 2025, with performance to be executed from the contractor's Conshohocken, Pennsylvania facility. The contract includes no set-aside designation, indicating it was awarded through open competition. Neupogen (filgrastim) is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,603.88 to AmerisourceBergen Drug Corp for Neupogen 480 mcg/0.8 mL syringes, with an ultimate completion date of September 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. Neupogen (filgrastim) is a granulocyte colony-stimulating factor used to support immune function in patients undergoing...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Neupogen 300 micrograms per milliliter vials, valued at $34,401.03 under a firm fixed-price contract. The award was made on a competitive, non-set-aside basis to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 9, 2025. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $12,549.14 to AmerisourceBergen Drug Corp for the supply of Neupogen 300 mcg/ml vials. The contract, awarded on August 18, 2025, with an ultimate completion date of August 19, 2025, utilizes firm fixed pricing with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under the company's broader...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 28, 2025, for the supply of Neupogen 300 mcg/mL vials with a ceiling value of $2,429.58. This is a firm fixed price, competitive delivery order with no set-aside designation and a completion date of July 29, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide Neupogen 480 mcg/0.8 mL syringes. The contract is a firm-fixed-price delivery order with a ceiling value of $4,019.12 and a performance period through June 23, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, that serves as a comprehensive global...
- This federal contract award is for the pharmaceutical product Neupogen 480 mcg/0.8 mL syringe, awarded to the prime contractor Amerisourcebergen Drug Corp. The $2,482.88 firm fixed price delivery order has an ultimate completion date of November 22, 2024. The contract was awarded on November 21, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency supplying medical products to military treatment facilities and veterans' healthcare programs. Amerisourcebergen, a...
- This federal contract award, valued at $3,644.34, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the NEUPOGEN 300 MCG/ML VIALML product, with a firm fixed price and an ultimate completion date of June 11, 2025. AmerisourceBergen Drug Corp, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of NEUPOGEN 300 MCG/ML vials to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The prime contractor is Amerisourcebergen Drug Corp, a large pharmaceutical distribution company. The contract has a ceiling value of $1,242.31 and is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency has awarded AmerisourceBergen Drug Corp a delivery order valued at $10,026.36 for Neulasta 6 mg/0.6 mL syringes, with completion targeted for August 7, 2025. The contract, issued on August 6, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. Performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...